Cargando…

Pemetrexed/carboplatin plus gefitinib as a first-line treatment for EGFR-mutant advanced nonsmall cell lung cancer: a Bayesian network meta-analysis

BACKGROUND: First-line treatments for nonsmall cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) mutations have been evaluated in various clinical trials. However, it remains unclear which is the optimal treatment. METHODS: A Bayesian network meta-analysis was used to assess...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zhonghan, Zeng, Kangmei, Zhao, Shen, Zhao, Yuanyuan, Hou, Xue, Luo, Fan, Lu, Feiteng, Zhang, Yaxiong, Zhou, Ting, Ma, Yuxiang, Yang, Yunpeng, Fang, Wenfeng, Huang, Yan, Zhang, Li, Zhao, Hongyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Meta-Analysis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937538/ https://www.ncbi.nlm.nih.gov/pubmed/31908655 http://dx.doi.org/10.1177/1758835919891652

Ejemplares similares

Dual blockade of EGFR and VEGFR pathways: Results from a pilot study evaluating apatinib plus gefitinib as a first‐line treatment for advanced EGFR‐mutant non‐small cell lung cancer
por: Zhang, Zhonghan, et al.
Publicado: (2020)

The ACTIVE study protocol: apatinib or placebo plus gefitinib as first-line treatment for patients with EGFR-mutant advanced non-small cell lung cancer (CTONG1706)
por: Zhang, Zhonghan, et al.
Publicado: (2019)

Efficacy and Tolerability of Erlotinib 100 mg/d vs. Gefitinib 250 mg/d in EGFR-Mutated Advanced Non-small Cell Lung Cancer (E100VG250): An Open-Label, Randomized, Phase 2 Study
por: Zhao, Shen, et al.
Publicado: (2020)

Phase III study of gefitinib or pemetrexed with carboplatin in EGFR-mutated advanced lung adenocarcinoma
por: Patil, Vijay Maruti, et al.
Publicado: (2017)

Assessment on the Efficacy and Safety of Aidi Injection Combined with Vinorelbine and Cisplatin for Treatment of Advanced Nonsmall Cell Lung Cancer
por: Zhao, Hua-Ye, et al.
Publicado: (2016)

Anticancer bispecific antibody R&D advances: a study focusing on research trend worldwide and in China
por: Zhang, Zhonghan, et al.
Publicado: (2021)

EGFR-TKI Plus Anti-Angiogenic Drugs in EGFR-Mutated Non–Small Cell Lung Cancer: A Meta-Analysis of Randomized Clinical Trials
por: Conforti, Fabio, et al.
Publicado: (2020)

Comparative efficacy and safety of anti-vascular endothelial growth factor regimens for neovascular age-related macular degeneration: systematic review and Bayesian network meta-analysis
por: Ye, Lu, et al.
Publicado: (2020)

Efficacy of different interventions for the treatment of postherpetic neuralgia: a Bayesian network meta-analysis
por: Wen, Bei, et al.
Publicado: (2020)

Furosemide with Saline Hydration for Prevention of Contrast-Induced Nephropathy in Patients undergoing Coronary Angiography: A Meta-Analysis of Randomized Controlled Trials
por: Duan, Nana, et al.
Publicado: (2015)

The efficacy and safety of paclitaxel and carboplatin with versus without bevacizumab in patients with non-small-cell lung cancer: a systematic review and meta-analysis
por: Han, Shiqian, et al.
Publicado: (2017)

Efficacy of statin treatment based on cardiovascular outcomes in elderly patients: a standard meta-analysis and Bayesian network analysis
por: Zhai, Chuannan, et al.
Publicado: (2020)

Comprehensive analyses of brain cell communications based on multiple scRNA‐seq and snRNA‐seq datasets for revealing novel mechanism in neurodegenerative diseases
por: Zhang, Chunlong, et al.
Publicado: (2023)

Clinical outcomes of WBRT plus EGFR-TKIs versus WBRT or TKIs alone for the treatment of cerebral metastatic NSCLC patients: a meta-analysis
por: Zheng, Hong, et al.
Publicado: (2017)

Comparison of the profiles of first-line PD-1/PD-L1 inhibitors for advanced NSCLC lacking driver gene mutations: a systematic review and Bayesian network meta-analysis
por: Wenfan, Fu, et al.
Publicado: (2023)

Pharmacological Therapies for Osteoporosis: A Bayesian Network Meta-Analysis
por: Shen, Jiping, et al.
Publicado: (2022)

Regional block techniques for pain management after video-assisted thoracoscopic surgery: a covariate-adjusted Bayesian network meta-analysis
por: Jiang, Tao, et al.
Publicado: (2023)

EGFR mutation genotypes affect efficacy and resistance mechanisms of osimertinib in T790M-positive NSCLC patients
por: Zheng, Qiufan, et al.
Publicado: (2020)

Afatinib as a Potential Therapeutic Option for Patients With NSCLC With EGFR G724S
por: Wei, Yang, et al.
Publicado: (2021)

Comparative efficacy and safety of various mechanical thrombectomy strategies for patients with acute ischemic stroke: a Bayesian network meta-analysis
por: Meng, Jiahao, et al.
Publicado: (2023)

Association between serum resistin concentration and hypertension: A systematic review and meta-analysis
por: Zhang, Yuxiang, et al.
Publicado: (2017)

Comparison of efficacy and tolerability of adjuvant therapy for resected high-risk stage III-IV cutaneous melanoma: a systemic review and Bayesian network meta-analysis
por: Ba, He, et al.
Publicado: (2023)

First-line therapeutic strategy for patients with advanced non–small cell lung cancer with Leu858Arg epidermal growth factor receptor mutations: a Bayesian network meta-analysis
por: Chen, Chongxiang, et al.
Publicado: (2022)

The therapeutic effect of splenectomy plus selective pericardial devascularization versus conventional pericardial devascularization on portal hypertension in China: a meta-analysis
por: Zhao, Yajie, et al.
Publicado: (2018)

Targeted first-line therapies for advanced colorectal cancer: a Bayesian meta-analysis
por: Ridouane, Yassine, et al.
Publicado: (2017)

Safety of different electrocautery modes for endoscopic sphincterotomy: a Bayesian network meta-analysis
por: Hedjoudje, Abdellah, et al.
Publicado: (2021)

EGFR T790M relative mutation purity predicts osimertinib treatment efficacy in non-small cell lung cancer patients
por: Zheng, Qiufan, et al.
Publicado: (2020)

Activity of pemetrexed and high-dose gefitinib in an EGFR-mutated lung adenocarcinoma with brain and leptomeningeal metastasis after response to gefitinib
por: Yuan, Ying, et al.
Publicado: (2012)

Sensitivity and identification quantification by a relative latent model complexity perturbation in Bayesian meta‐analysis
por: Roos, Małgorzata, et al.
Publicado: (2021)

Network Meta-Analysis of Erlotinib, Gefitinib, Afatinib and Icotinib in Patients with Advanced Non-Small-Cell Lung Cancer Harboring EGFR Mutations
por: Liang, Wenhua, et al.
Publicado: (2014)

Telomere Reverse Transcriptase (TERT) rs2735940 Increases Cancer Risk
por: Yang, Hui, et al.
Publicado: (2015)

Comparison of Surgical Techniques in Living Donor Nephrectomy: A Systematic Review and Bayesian Network Meta-Analysis
por: Xiao, Qi, et al.
Publicado: (2020)

Diagnostic value of supersonic shear impulse elastography for malignant cervical lymph nodes: a Bayesian analysis
por: Qiu, Yuxuan, et al.
Publicado: (2022)

Efficacy and safety of first-line PD-1/PD-L1 inhibitor combinations for extensive-stage small-cell lung cancer: a Bayesian network meta-analysis
por: Li, Huijuan, et al.
Publicado: (2023)

Association between red and processed meat intake and colorectal adenoma incidence and recurrence: a systematic review and meta-analysis
por: Zhao, Zhanwei, et al.
Publicado: (2017)

Optimal tumor shrinkage predicts long-term outcome in advanced nonsmall cell lung cancer (NSCLC) treated with target therapy: Result from 3 clinical trials of advanced NSCLC by 1 institution
por: He, Xiaobo, et al.
Publicado: (2016)

Common Polymorphisms in IL-27 Genes May Contribute to Risk of Various Human Diseases in Asian Populations: A Meta-Analysis
por: Zhang, Yun-Feng, et al.
Publicado: (2016)

Prognostic and pathological impact of tumor budding in gastric cancer: A systematic review and meta-analysis
por: Guo, Yi-Xian, et al.
Publicado: (2019)

Efficacy of pharmacotherapeutics for patients comorbid with alcohol use disorders and depressive symptoms—A bayesian network meta‐analysis
por: Li, Jiande, et al.
Publicado: (2020)

Meta-Analysis of Combination Therapy of Chinese Herbs Plus Interferon and Ribavirin in Patients with Chronic Hepatitis C
por: Wang, Jianjun, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_le5ce74pu4p77gj3rn095ijv76